Aktuelle Publikationsliste der HNO-Klinik

Publikationen nach Jahrgängen:

isTab: true
Zurück
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
Vor

Cetuximab resistance in head and neck cancer is mediated by EGFR-K521 polymorphism
Braig F, Kriegs M, Habel B, Voigtländer M, Grob T, Biskup K, Blanchard V, Sack M, Thalhammer A, Ben Batalla I, Braren I, Laban S, Danielczyk A, Goletz S, Jakubowicz E, Märkl B, Trepel M, Knecht R, Riecken K, Fehse B, Loges S, Bokemeyer C, Binder M
CANCER RES. 2017;77(5):1188–1199.

G2-checkpoint targeting and radiosensitization of HPV/p16-positive HNSCC cells through the inhibition of Chk1 and Wee1
Busch C, Kröger M, Jensen J, Kriegs M, Gatzemeier F, Petersen C, Münscher A, Rothkamm K, Rieckmann T
RADIOTHER ONCOL. 2017;122(2):260-266.

Facial mimetic, cosmetic, and functional standardized assessment of the facial artery musculomucosal (FAMM) flap
Jowett N, Hadlock T, Sela E, Toth M, Knecht R, Lörincz B
AURIS NASUS LARYNX. 2017;44(2):220-226.

Seasonal differences of tympanogram and middle ear findings in children
Knopke S, Böttcher A, Chadha P, Olze H, Bast F
HNO. 2017;65(Suppl 1):68-72.

Bilateral vagal automatic periodic stimulation in single-incision transaxillary robotic total thyroidectomy
Aïdan P, Chung W, Lörincz B
CLIN OTOLARYNGOL. 2016 [Epub ahead of print].

DNA Repair
Borgmann K, Köcher S, Kriegs M, Mansour Khalfallah W, Parplys A, Rieckmann T, Rothkamm K
2016. Molecular Radio-Oncology. Baumann M, Krause M, Cordes N (Hrsg.). 1. Aufl. Berlin Heidelberg: Springer-Verlag GmbH Berlin Heidelberg, 1-24.

Liquid biopsy monitoring uncovers acquired RAS-mediated resistance to cetuximab in a substantial proportion of patients with head and neck squamous cell carcinoma
Braig F, Voigtländer M, Schieferdecker A, Busch C, Laban S, Grob T, Kriegs M, Knecht R, Bokemeyer C, Binder M
ONCOTARGET. 2016;7(28):42988-42995.

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines
Busch C, Becker B, Kriegs M, Gatzemeier F, Krüger K, Möckelmann N, Fritz G, Petersen C, Knecht R, Rothkamm K, Rieckmann T
ONCOTARGET. 2016;7(24):35832-35842.

Postoperative antibiotic prophylaxis in clean-contaminated head and neck oncologic surgery: a retrospective cohort study
Busch C, Knecht R, Münscher A, Matern J, Dalchow C, Lörincz B
EUR ARCH OTO-RHINO-L. 2016;273(9):2805-11.

Immuntherapeutische Studien bei Kopf-Hals-Tumoren: Highlights der ASCO-Jahrestagung 2016
Busch C, Laban S, Knecht R, Hoffmann T
HNO. 2016;64(10):708-16.

Perspectives in chemosensitivity and chemoresistance assays and their implementation in head and neck cancer
Bussmann L, Busch C, Lörincz B, Rieckmann T, Block A, Knecht R
EUR ARCH OTO-RHINO-L. 2016;273(12):4073-4080.

Therapie der rezidivierten und fernmetastasierten Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2016
Bußmann L, Busch C, Knecht R
HNO. 2016;64(10):723-30.

DNA repair after oncological therapy (radiotherapy and chemotherapy)
Dikomey E, Borgmann K, Kriegs M, Mansour Khalfallah W, Petersen C, Rieckmann T
2016. Oxford Textbook of Oncology. Kerr D, Haller D, van de Velde C, Baumann M (Hrsg.). 3. Aufl. Oxford: Oxford University Press, 82-85.

Radiation DNA damage and use in cancer/therapeutics-translation of radiation modifiers
Dikomey E, Borgmann K, Köcher S, Kriegs M, Mansour Khalfallah W, Parplys A, Rieckmann T, Rothkamm K
2016. DNA Repair in Cancer Therapy. Kelley M, Fishel M (Hrsg.). 2. Aufl. London: Elsevier Science, 329 - 352.

Immuntherapie des HNSCC: Quo vadis?
Döscher J, Busch C, Schuler P, Laban S
HNO. 2016;64(10):700-7.

Targeted nanoparticles for tumour radiotherapy enhancement - the long dawn of a golden era?
Gargioni E, Schulz F, Raabe A, Burdak-Rothkamm S, Rieckmann T, Rothkamm K
Ann Transl Med. 2016;4(24):523.

Studienergebnisse zur Primärtherapie von Kopf-Hals-Tumoren: Highlights der ASCO-Jahrestagung 2016
Gliese A, Busch C, Knecht R
HNO. 2016;64(10):717-22.

A nyaki dissectiók onkológiai hozamának maximalizálása a sebészi morbiditás egyidejű minimalizálása mellett
Háromi I, Gerlinger I, Lujber L, Lörincz B
ORVOSI HETILAP. 2016;157(47):1871-1879.

Endpoints and cutpoints in head and neck oncology trials: methodical background, challenges, current practice and perspectives
Hezel M, von Usslar K, Kurzweg T, Lörincz B, Knecht R
EUR ARCH OTO-RHINO-L. 2016;273(4):837-44.

Oncologic treatment landscape for head and neck squamous cell carcinoma: Treatment infrastructure in German-speaking countries
Kimmeyer J, Kurzweg T, Hoffmann T, Knecht R, Veit J, Möckelmann N, Münscher A, Laban S
HNO. 2016;64(7):494-500.

Ist Radio(chemo)therapie wirklich der zukünftige Standard für die Behandlung von Oropharynxkarzinomen?
Knecht R, Bussmann L, Möckelmann N, Lörincz B
HNO. 2016;64(4):221-6.

Aktuelle Therapiekonzepte bei Kopf-Hals-Tumoren: Highlights des ASCO Annual Meeting 2016
Knecht R
HNO. 2016;64(10):699.

Saisonale Unterschiede von Tympanogramm- und Mittelohrbefund bei Kindern
Knopke S, Böttcher A, Chadha P, Olze H, Bast F
HNO. 2016 [Epub ahead of print].

Radiosensitization of HNSCC cells by EGFR inhibition depends on the induction of cell cycle arrests
Kriegs M, Kasten-Pisula U, Riepen B, Hoffer K, Struve N, Myllynen L, Braig F, Binder M, Rieckmann T, Grénman R, Petersen C, Dikomey E, Rothkamm K
ONCOTARGET. 2016;7(29):45122-45133.

Situation of young radiation oncologists, medical physicists and radiation biologists in German-speaking countries: Results from a web-based survey of the Young DEGRO working group
Krug D, Baumann R, Rieckmann T, Fokas E, Gauer T, Niyazi M
STRAHLENTHER ONKOL. 2016;192(8):507-15.

Curative treatment of head and neck squamous cell carcinoma: Organ preservation strategies in clinical routine in German-speaking countries
Kurzweg T, Kimmeyer J, Knecht R, Hoffmann T, Busch C, Lörincz B, Schuler P, Laban S
HNO. 2016;64(7):501-7.

Homogenization of tissues via picosecond-infrared laser (PIRL) ablation: Giving a closer view on the in-vivo composition of protein species as compared to mechanical homogenization
Kwiatkowski M, Wurlitzer M, Krutilin A, Kiani P, Nimer R, Omidi M, Mannaa A, Bussmann T, Bartkowiak K, Kruber S, Uschold S, Steffen P, Lübberstedt J, Küpker N, Petersen H, Knecht R, Hansen N, Zarrine-Afsar A, Robertson W, Miller R, Schlüter H
J PROTEOMICS. 2016;134:193-202.

Palliative treatment standards for head and neck squamous cell carcinoma: Survey of clinical routine in German-speaking countries
Laban S, Kimmeyer J, Knecht R, Hoffmann T, Busch C, Veit J, Möckelmann N, Kurzweg T
HNO. 2016;64(7):487-93.

The impact of surgical technique on neck dissection nodal yield making a difference
Lörincz B, Langwieder F, Möckelmann N, Sehner S, Knecht R
EUR ARCH OTO-RHINO-L. 2016;273(5):1261–1267.

Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective
Lörincz B, Jowett N, Knecht R
HEAD NECK-J SCI SPEC. 2016;38 (Suppl 1):E2190-6.

Neue Aspekte in der Therapie von Schilddrüsenkarzinomen: Highlights des ASCO-Kongresses 2016
Lörincz B, Simon C, Möckelmann N, Knecht R
HNO. 2016;64(10):736-40.

Molecular targeting in combination with platinum-based chemoradiation in head and neck cancer treatment
Möckelmann N, Kriegs M, Lörincz B, Busch C, Knecht R
HEAD NECK-J SCI SPEC. 2016;38(Suppl 1):E2173-81.

Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells
Möckelmann N, Rieckmann T, Busch C, Becker B, Gleißner L, Hoffer K, Omniczynski M, Steinmeister L, Laban S, Grénman R, Petersen C, Rothkamm K, Dikomey E, Knecht R, Kriegs M
ONCOTARGET. 2016;7(17):23542-51.

CD151 expression is frequent but unrelated to clinical outcome in head and neck cancer.
Nienstedt J, Gröbe A, Lebok P, Büscheck F, Clauditz T, Simon R, Heumann A, Sauter G, Möbius C, Münscher A, Knecht R, Blessmann M, Heiland M, Pflug C
CLIN ORAL INVEST. 2016 [Epub ahead of print].

Comparative study of wound healing in rat skin following incision with a novel picosecond infrared laser (PIRL) and different surgical modalities
Petersen H, Tavakoli F, Kruber S, Münscher A, Gliese A, Hansen N, Uschold S, Eggert D, Robertson W, Gosau T, Sehner S, Kwiatkowski M, Schlüter H, Schumacher U, Knecht R, Miller R
LASER SURG MED. 2016;48(4):385-91.

Survival and overall treatment time after postoperative radio(chemo)therapy in patients with head and neck cancer
Tribius S, Donner J, Pazdyka H, Münscher A, Gröbe A, Petersen C, Krüll A, Tennstedt P
HEAD NECK-J SCI SPEC. 2016;38(7):1058-1065.

PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
Wurster S, Hennes F, Parplys A, Seelbach J, Mansour Khalfallah W, Zielinski A, Petersen C, Clauditz T, Münscher A, Friedl A, Borgmann K
ONCOTARGET. 2016;7(9):9732-41.

Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature
Zielinski V, Laban S, Tribius S, Schafhausen P, Veldhoen S, Knecht R, Clauditz T, Muenscher A
ENT-EAR NOSE THROAT. 2016;95(1):23-8.

Long-term vestibulocochlear functional outcome following retro-sigmoid approach to resection of vestibular schwannoma
Abboud T, Regelsberger J, Matschke J, Jowett N, Westphal M, Dalchow C
EUR ARCH OTO-RHINO-L. 2015;273(3):719-725.

Prognostic factors for survival of patients with newly diagnosed chronic GVHD according to NIH criteria
Ayuketang F, Veit R, Zabelina T, Bussmann L, Christopeit M, Alchalby H, Wolschke C, Lellek H, Bacher U, Zander A, Kröger N
ANN HEMATOL. 2015;94(10):1727-32.

Reduction of thermocoagulative injury via use of a picosecond infrared laser (PIRL) in laryngeal tissues
Böttcher A, Kucher S, Knecht R, Jowett N, Krötz P, Reimer R, Schumacher U, Anders S, Münscher A, Dalchow C, Miller R
EUR ARCH OTO-RHINO-L. 2015;272(4):941-8.

The current role of systemic chemotherapy in the primary treatment of head and neck cancer
Busch C, Tribius S, Schafhausen P, Knecht R
CANCER TREAT REV. 2015;41(3):217-21.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs:Highlights des ASCO-Meetings 2015
Bußmann L, Busch C, Knecht R
HNO. 2015;63(9):620-4.

First results of Endonasal dilatation of the Eustachian tube (EET) in patients with chronic obstructive tube dysfunction
Dalchow C, Loewenthal M, Kappo N, Jenckel F, Loerincz B, Knecht R
EUR ARCH OTO-RHINO-L. 2015;273(3):607-613.

HPV and Radiation Sensitivity
De Costa A, Rieckmann T, Kimple R
2015. Human Papillomavirus (HPV)-Associated Oropharyngeal Cancer. Miller D, Stack M (Hrsg.). 1. Aufl. Springer, 243-289.

Überblick der Cochleostomieverfahren mit Fokussierung auf neue Laserablationstechniken
Elsholz A, Böttcher A, Knecht R, Dalchow C
LARYNGORHINOOTOLOGIE. 2015;94(7):437-40.

Reduced dosage of bevacizumab in treatment of vestibular schwannomas in patients with neurofibromatosis type 2
Farschtschi S, Kollmann P, Dalchow C, Stein A, Mautner V
EUR ARCH OTO-RHINO-L. 2015;272(12):3857-60.

Die wichtigsten Studienergebnisse zur nicht-chirurgischen Primärtherapie lokal fortgeschrittener Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2015
Gliese A, Busch C, Knecht R
HNO. 2015;63(9):606-611.

Endonasal dilatation of the Eustachian tube (EET) in children: feasibility and the role of tubomanometry (Estève) in outcomes measurement
Jenckel F, Kappo N, Gliese A, Loewenthal M, Lörincz B, Knecht R, Dalchow C
EUR ARCH OTO-RHINO-L. 2015;272(12):3677-3683.

Aktuelle Therapiekonzepte bei Kopf-Hals-Tumoren: Highlights des Jahrestreffens der American Society for Clinical Oncology 2015
Knecht R
HNO. 2015;63(9):605.

2. Kommentar zu: 99mTc Tilmanocept und SPECT / CT zur Suche nach regionalen Lymphknotenmetastasen (JAMA Otolaryngol Head Neck Surg 2013; 139: 895–902)
Knecht R
LARYNGORHINOOTOLOGIE. 2015;94(5):289.

Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest
Kriegs M, Gurtner K, Can Y, Brammer I, Rieckmann T, Oertel R, Wysocki M, Dorniok F, Gal A, Grob T, Laban S, Kasten-Pisula U, Petersen C, Baumann M, Krause M, Dikomey E
RADIOTHER ONCOL. 2015;115(1):120-7.

A New Technology for Applanation Free Corneal Trephination: The Picosecond Infrared Laser (PIRL)
Linke S, Frings A, Ren L, Gomolka A, Schumacher U, Reimer R, Hansen N, Jowett N, Richard G, Miller R
PLOS ONE. 2015;10(3):e0120944.

A comparison of hearing results following stapedotomy under local versus general anesthesia
Loewenthal M, Jowett N, Busch C, Knecht R, Dalchow C
EUR ARCH OTO-RHINO-L. 2015;272(9):2121-7.

Feasibility and safety of transoral robotic surgery (TORS) for early hypopharyngeal cancer: a subset analysis of the Hamburg University TORS-trial
Lörincz B, Busch C, Möckelmann N, Knecht R
EUR ARCH OTO-RHINO-L. 2015;272(10):2993-2998.

Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: Single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma
Lörincz B, Möckelmann N, Busch C, Knecht R
HEAD NECK-J SCI SPEC. 2015;37(11):1618-1624.

Initial learning curve of single-incision transaxillary robotic hemi- and total thyroidectomy--A single team experience from Europe
Lörincz B, Busch C, Möckelmann N, Knecht R
INT SURG. 2015;18:118-22.

Two-Year Survival Analysis of 50 Consecutive Head and Neck Cancer Patients Treated with Transoral Robotic Surgery in a Single European Centre
Lörincz B, Möckelmann N, Busch C, Münscher A, Sehner S, Dalchow C, Knecht R
ANN SURG ONCOL. 2015;22:S1028-S1033.

Automatic periodic stimulation of the vagus nerve during single-incision transaxillary robotic thyroidectomy: Feasibility, safety, and first cases
Lörincz B, Möckelmann N, Busch C, Hezel M, Knecht R
HEAD NECK-J SCI SPEC. 2015;38(3):482-485.

Extent of Lateral Neck Dissection in Differentiated Thyroid Carcinoma
Lörincz B, Knecht R
DTSCH ARZTEBL INT. 2015;112(42):722.

Neue Aspekte in der Therapie von Schilddrüsenkarzinomen
Lörincz B, Topp S, Knecht R
HNO. 2015;63(9):625-8.

TORS for head and neck squamous cell carcinoma (HNSCC): the Hamburg experience
Lörincz B, Knecht R
B-ENT. 2015;Suppl 24:33-6.

A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
Machiels J, Specenier P, Krauß J, Dietz A, Kaminsky M, Lalami Y, Henke M, Keilholz U, Knecht R, Skartved N, Horak I, Pamperin P, Braun S, Gauler T
CANCER CHEMOTH PHARM. 2015;76(1):13-20.

Timing of neck dissection in patients undergoing transoral robotic surgery for head and neck cancer
Möckelmann N, Busch C, Münscher A, Knecht R, Lörincz B
EJSO-EUR J SURG ONC. 2015.

Robotic-assisted selective and modified radical neck dissection in head and neck cancer patients
Möckelmann N, Lörincz B, Knecht R
INT SURG. 2015;25:24-30.

Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation
Münscher A, Sehner S, Taleh J, Tribius S, Möckelmann N, Böttcher A, Gulati A, Dalchow C, Clauditz T, Knecht R
EUR ARCH OTO-RHINO-L. 2015;272(7):1769-75.

The antileukoprotease secretory leukocyte protease inhibitor (SLPI) and its role in the prevention of HPV-infections in head and neck squamous cell carcinoma
Quabius E, Görögh T, Fischer G, Hoffmann A, Gebhard M, Evert M, Beule A, Maune S, Knecht R, Óvári A, Durisin M, Hoppe F, Röcken C, Hedderich J, Ambrosch P, Hoffmann M
CANCER LETT. 2015;357(1):339-45.

Geographical and anatomical influences on human papillomavirus prevalence diversity in head and neck squamous cell carcinoma in Germany
Quabius E, Haag J, Kühnel A, Henry H, Hoffmann A, Görögh T, Hedderich J, Evert M, Beule A, Maune S, Knecht R, Óvári A, Durisin M, Hoppe F, Tribius S, Röcken C, Ambrosch P, Hoffmann M
INT J ONCOL. 2015;46(1):414-22.

EGFRvIII does not affect radiosensitivity with or without gefitinib treatment in glioblastoma cells
Struve N, Riedel M, Schulte A, Rieckmann T, Grob T, Gal A, Rothkamm K, Lamszus K, Petersen C, Dikomey E, Kriegs M
ONCOTARGET. 2015;6(32):33867-77.

Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer: Results of a prospective study
Tribius S, Raguse M, Voigt C, Münscher A, Gröbe A, Petersen C, Krüll A, Bergelt C, Singer S
STRAHLENTHER ONKOL. 2015.

Use of a microsecond Er:YAG laser in laryngeal surgery reduces collateral thermal injury in comparison to superpulsed CO2 laser
Böttcher A, Jowett N, Kucher S, Reimer R, Schumacher U, Knecht R, Wöllmer W, Münscher A, Dalchow C
EUR ARCH OTO-RHINO-L. 2014;271(5):1121-8.

Laryngeal injuries following endotracheal intubation in ENT surgery: predictive value of anatomical scores
Böttcher A, Mencke T, Zitzmann A, Knecht R, Jowett N, Nöldge-Schomburg G, Pau H, Dommerich S
EUR ARCH OTO-RHINO-L. 2014;271(2):345-52.

Continuous tissue microarray based identification of cancers with homogeneous target expression for successful targeted therapy in clinical routine practice
Burandt E, Schreiber M, Stein A, Minner S, Clauditz T, Bokemeyer C, Jänicke F, Fisch M, Izbicki J, Knecht R, Sauter G, Stahl P
GENE CHROMOSOME CANC. 2014;53(3):228-39.

Activated leukocyte cell adhesion molecule (ALCAM/CD166) expression in head and neck squamous cell carcinoma (HNSSC)
Clauditz T, von Rheinbaben K, Lebok P, Minner S, Tachezy M, Borgmann K, Knecht R, Sauter G, Wilczak W, Blessmann M, Münscher A
PATHOL RES PRACT. 2014;210(10):649-655.

Die wichtigsten Studienergebnisse in der Primärtherapie von Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2014
Gliese A, Busch C, Knecht R
HNO. 2014;62(11):781-6.

The inhibition of PARP but not EGFR results in the radiosensitization of HPV/p16-positive HNSCC cell lines
Güster J, Weissleder S, Busch C, Kriegs M, Petersen C, Knecht R, Dikomey E, Rieckmann T
RADIOTHER ONCOL. 2014;113(3):345-51.

Bone ablation without thermal or acoustic mechanical injury via a novel picosecond infrared laser (PIRL)
Jowett N, Wöllmer W, Reimer R, Zustin J, Schumacher U, Wiseman P, Mlynarek A, Böttcher A, Dalchow C, Lörincz B, Knecht R, Miller R
OTOLARYNG HEAD NECK. 2014;150(3):385-93.

Induktionschemotherapie bei lokal fortgeschrittenen Kopf-Hals-Karzinomen – pro
Knecht R, Busch C, Schafhausen P
DEUT MED WOCHENSCHR. 2014;139(41):2080.

Aktuelle Therapiekonzepte bei Kopf-Hals-Tumoren: Highlights zum 50. Jubiläum der ASCO 2014
Knecht R
HNO. 2014;62(11):780.

Therapie von Kopf-Hals-Karzinomen
Knecht R, Busch C, Lörincz B, Schafhausen P, Tribius S, Heiland M, Jenckel F, Münscher A, Petersen C, Bokemeyer C
Hamb Arztebl. 2014;8:12-17.

Inventory of economic evaluation of head and neck oncology from the German perspective
Kurzweg T, Knecht R
EUR ARCH OTO-RHINO-L. 2014;271(10):2611-2616.

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer
Laban S, Atanackovic D, Luetkens T, Knecht R, Busch C, Freytag M, Spagnoli G, Ritter G, Hoffmann T, Knuth A, Sauter G, Wilczak W, Blessmann M, Borgmann K, Münscher A, Clauditz T
INT J CANCER. 2014.

Perspektiven der laserassistierten Keratoplastik: Eine aktuelle Übersicht und erste experimentelle Erfahrungen mit dem Pikosekundeninfrarotlaser (λ = 3 µm)
Linke S, Ren L, Frings A, Steinberg J, Wöllmer W, Katz T, Reimer R, Hansen N, Jowett N, Richard G, Dwayne Miller R
OPHTHALMOLOGE. 2014;111(6):523-30.

Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation
Lörincz B, Möckelmann N, Knecht R
EUR ARCH OTO-RHINO-L. 2014;271(12):3349-53.

pERK 1/2 inhibit Caspase-8 induced apoptosis in cancer cells by phosphorylating it in a cell cycle specific manner
Mandal R, Raab M, Matthess Y, Becker S, Knecht R, Strebhardt K
MOL ONCOL. 2014;8(2):232-49.

Sequential Cdk1 and Plk1 phosphorylation of caspase-8 triggers apoptotic cell death during mitosis
Matthess Y, Raab M, Knecht R, Becker S, Strebhardt K
MOL ONCOL. 2014;8(3):596-608.

Circulating tumor cells in head and neck cancer: clinical impact in diagnosis and follow-up
Möckelmann N, Laban S, Pantel K, Knecht R
EUR ARCH OTO-RHINO-L. 2014;271(1):15-21.

ERCC 1 – Eine Expressionsanalyse in laryngealen Plattenepithelkarzinomen
Prochnow S, Knecht R, Münscher A
2014.

Quantitative chemical proteomics reveals a Plk1 inhibitor-compromised cell death pathway in human cells
Raab M, Pachl F, Krämer A, Kurunci-Csacsko E, Dötsch C, Knecht R, Becker S, Kuster B, Strebhardt K
CELL RES. 2014;24(9):1141-1145.

Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2014
Zeller N, Busch C, Schafhausen P, Knecht R, Möckelmann N
HNO. 2014;62(11):787-92.

Hereditäre sensorineurale Schwerhörigkeit und Makrothrombozytopenie: Eine seltene Mutation des MYH9-Gens
Böttcher A, Knecht R, Busch C, Lörincz B, Dalchow C
HNO. 2013;61(2):159-60, 162-5.

Distribution of circulating natural killer cells and T lymphocytes in head and neck squamous cell carcinoma.
Böttcher A, Ostwald J, Guder E, Pau H, Kramp B, Dommerich S
AURIS NASUS LARYNX. 2013;40(2):216-221.

A novel tool in laryngeal surgery: preliminary results of the picosecond infrared laser
Böttcher A, Clauditz T, Knecht R, Kucher S, Wöllmer W, Wilczak W, Krötz P, Jowett N, Dalchow C, Münscher A, Miller R
LARYNGOSCOPE. 2013;123(11):2770-5.

Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma
Böttcher A, Ostwald J, Koczan D, Knecht R, Kramp B, Dommerich S
Cancer Genomics & Proteomics. 2013;10(5):197-207.

HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1
Busch C, Kriegs M, Laban S, Tribius S, Knecht R, Petersen C, Dikomey E, Rieckmann T
RADIOTHER ONCOL. 2013;108(3):495-9.

Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target?
Clauditz T, Gontarewicz A, Bokemeyer C, Sauter G, Knecht R, Münscher A, Wilczak W
J ORAL PATHOL MED. 2013;42(10):769-73.

Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck
Clauditz T, Busch C, Gontarewicz A, Blessmann M, Tennstedt P, Borgmann K, Tribius S, Sauter G, Dalchow C, Knecht R, Münscher A, Wilczak W
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology. 2013;42(2):125-32.

The effect of intratympanic methylprednisolone and gentamicin injection on Ménière's disease.
Dalchow C, Madjani O
LARYNGORHINOOTOLOGIE. 2013;11:720-721.

Was hilft besser: Intratympanales Gentamicin oder Methylprednisolon?
Dalchow C, Majdani O
LARYNGORHINOOTOLOGIE. 2013;92(11):720-1.

Investigation of noise levels generated by otologic drills
Dalchow C, Hagemeier K, Münscher A, Knecht R, Kameier F
EUR ARCH OTO-RHINO-L. 2013;270(2):505-510.

Radiographic examination of patients with dehiscence of semicircular canals with digital volume tomography
Dalchow C, Knecht R, Grzyska U, Münscher A
EUR ARCH OTO-RHINO-L. 2013;270(2):511-9.

Picosecond infrared laser (PIRL): an ideal phonomicrosurgical laser?
Hess M, Hildebrandt M, Müller F, Kruber S, Kroetz P, Schumacher U, Reimer R, Kammal M, Püschel K, Wöllmer W, Miller D
EUR ARCH OTO-RHINO-L. 2013;270(11):2927-37.

Therapie der Rezidiv- und Fernmetastasen bei Plattenepithelkarzinomen des Kopf- und Halsbereichs: Highlights des ASCO-Meetings 2013
Hezel M, Kurzweg T, Münscher A, Schafhausen P, Knecht R
HNO. 2013;61(11):911-3.

State of the art in the treatment of laryngeal cancer
Jenckel F, Knecht R
ANTICANCER RES. 2013;33(11):4701-10.

Heat generation during ablation of porcine skin with erbium:YAG laser vs a novel picosecond infrared laser
Jowett N, Wöllmer W, Mlynarek A, Wiseman P, Segal B, Franjic K, Krötz P, Böttcher A, Knecht R, Miller R
JAMA Otolaryngol-Head & Neck Surg. 2013;139(8):828-33.

Multimodalität und Interdisziplinarität in der Krebstherapie.
Knecht R
HNO. 2013;61(11):904.

New treatment strategies for HPV-positive head and neck cancer
Kofler B, Laban S, Busch C, Lörincz B, Knecht R
EUR ARCH OTO-RHINO-L. 2013.

Laryngeal dislocation after ventral fusion of the cervical spine
Krauel J, Winkler D, Münscher A, Tank S
Indian journal of anaesthesia. 2013;57(3):285-8.

Molecular targeting agents in the context of primary chemoradiation strategies.
Laban S, Busch C, Münscher A, Tribius S, Schafhausen P, Knecht R
HEAD NECK-J SCI SPEC. 2013;35(5):738-746.

Sorafenib sensitizes head and neck squamous cell carcinoma cells to ionizing radiation
Laban S, Steinmeister L, Gleißner L, Grob T, Grénman R, Petersen C, Gal A, Knecht R, Dikomey E, Kriegs M
RADIOTHER ONCOL. 2013;109(2):286-92.

Roboter-assistierte transorale Tumorchirurgie möglich
Lörincz B, Mandapathil M
LARYNGORHINOOTOLOGIE. 2013;92(10):642-3.

Roboterassistierte Salvage Laryngektomie und Neck Dissection: das Konzept "Robotic Combo Surgery"
Lörincz B, Knecht R
LARYNGORHINOOTOLOGIE. 2013;92(9):585-8.

Die Entwicklung von TORS in Europa
Lörincz B, Laban S, Knecht R
HNO. 2013;61(4):294-9.

Die wichtigsten Studienergebnisse der primären Radio-Chemo-Therapie von Kopf-Hals-Tumoren: Highlights des ASCO-Meetings 2013
Münscher A, Busch C, Schafhausen P, Tribius S, Knecht R
HNO. 2013;61(11):905-10.

HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity.
Rieckmann T, Tribius S, Grob T, Meyer F, Busch C, Petersen C, Dikomey E, Kriegs M
RADIOTHER ONCOL. 2013;107(2):242-246.

Ductus-thyreoglossus-Zystenkarzinom im Rahmen eines multizentrischen papillären Schilddrüsenkarzinoms
Ritzel R, Bier J, Habermann C
ROFO-FORTSCHR RONTG. 2013;185(1):76-7.

Measurement and comparison of labyrinthine structures with the digital volume tomography: ancient Egyptian mummies' versus today's temporal bones.
Schmidt C, Harbort J, Knecht R, Grzyska U, Münscher A, Dalchow C
EUR ARCH OTO-RHINO-L. 2013;270(3):831-840.

Xerostomia after radiotherapy. What matters--mean total dose or dose to each parotid gland?
Tribius S, Sommer J, Prosch C, Bajrovic A, Münscher A, Blessmann M, Krüll A, Petersen C, Todorovic M, Tennstedt P
STRAHLENTHER ONKOL. 2013;189(3):216-222.

LASER Safety through international information interchange: An introduction to the International Laser Safety Conference (ILSC®) and report of the "ILSC 2013"
Wöllmer W
Photonic Laser Med. 2013;2(3):257-259.

Does a New Photoablative Laser Set Fire On Endotracheal Tubes?
Wöllmer W, Hildebrandt M, Jowett N, Kroetz P, Franjic K, Müller F, Knecht R, Kucher S, Böttcher A, Miller R
2013;217.

Enhanced podoplanin expression in chronic maxillary sinusitis
Zustin J, Scheuer H, Knecht R, Friedrich R
IN VIVO. 2013;27(4):551-4.

11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma
Clauditz T, Gontarewicz A, Wang C, Münscher A, Laban S, Tsourlakis M, Knecht R, Sauter G, Wilczak W
DIAGN MOL PATHOL. 2012;21(3):134-137.

Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.
Clauditz T, Gontarewicz A, Lebok P, Tsourlakis M, Grob T, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W
ORAL ONCOL. 2012;48(10):991-996.

Epidermal growth factor receptor (EGFR) in salivary gland carcinomas
Clauditz T, Gontarewicz A, Lebok P, Tsourlakis M, Grob T, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W
ORAL ONCOL. 2012;48(10):991-6.

Imaging of ancient Egyptian mummies' temporal bones with digital volume tomography.
Dalchow C, Schmidt C, Harbort J, Knecht R, Grzyska U, Münscher A
EUR ARCH OTO-RHINO-L. 2012;269(10):2277-2284.

Metastatic head and neck cutaneous squamous cell carcinoma: defining a low-risk patient.
Ebrahimi A, Clark J, Lörincz B, Milross C, Veness M
HEAD NECK-J SCI SPEC. 2012;34(3):365-370.

Chromosomal rearrangements in PLAG1 of myoepithelial salivary gland tumours.
Friedrich R, Dilcher J, Jaehne M, Löning T
ANTICANCER RES. 2012;32(5):1977-1981.

[Isolated taste disorder as primary symptom of a chronic inflammatory middle ear disease].
Guder E, Böttcher A, Just T
LARYNGORHINOOTOLOGIE. 2012;91(1):34-35.

Taste function after stapes surgery.
Guder E, Böttcher A, Pau H, Just T
AURIS NASUS LARYNX. 2012;39(6):562-566.

Neue Aspekte HPV-positiver Kopf-Hals-Karzinome. Highlights vom ASCO-Kongress 2011
Kofler B, Uecker F, Muenscher A, Knecht R
HNO. 2012;60(5):404-7.

[New aspects of HPV-positive head and neck cancer. Highlights from the 2011 ASCO Congress].
Kofler B, Uecker F, Münscher A, Knecht R
HNO. 2012;60(5):404-407.

Current treatment options for recurrent/metastatic head and neck cancer
Kurzweg T, Möckelmann N, Laban S, Knecht R
EUR ARCH OTO-RHINO-L. 2012;269(10):2157-67.

Current treatment options for recurrent/metastatic head and neck cancer: a post-ASCO 2011 update and review of last year's literature.
Kurzweg T, Möckelmann N, Laban S, Knecht R
EUR ARCH OTO-RHINO-L. 2012;269(10):2157-2167.

Die wichtigsten Studienergebnisse der primären Radiochemotherapie von Kopf-Hals-Tumoren
Laban S, Zielinski V, Busch C, Münscher A, Schafhausen P, Tribius S, Knecht R
HNO. 2012;60(11):962-7.

Neue Aspekte der primären Radiochemotherapie bei Kopf-Hals-Tumoren. Highlights vom ASCO-Kongress 2011
Laban S, Wang C, Knecht R, Tribius S, Münscher A
HNO. 2012;60(5):393-7.

[New aspects of primary radiochemotherapy in head and neck cancer : Highlights from the 2011 ASCO Congress].
Laban S, Wang C, Knecht R, Tribius S, Münscher A
HNO. 2012;60(5):393-397.

[The most important results on primary chemoradiation for head and neck squamous cell carcinoma: highlights from the 2012 ASCO meeting].
Laban S, Zielinski V, Busch C, Münscher A, Schafhausen P, Tribius S, Knecht R
HNO. 2012;60(11):962-967.

[Oncological nonsurgical treatment concepts for head and neck tumors: highlights from the 2012 ASCO annual meeting].
Laban S, Knecht R
HNO. 2012;60(11):950.

Neue Aspekte zur aktuellen Therapie von Oropharynxkarzinomen
Loewenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, Busch C
HNO. 2012;60(11):951-6.

[New aspects of current therapeutic strategies in oropharyngeal carcinoma: highlights of the 2012 ASCO meeting].
Löwenthal M, Vitez E, Laban S, Münscher A, Güldenzoph B, Knecht R, Busch C
HNO. 2012;60(11):951-956.

New aspects of induction chemotherapy for head and neck cancer: POSTASCO 2011.
Mumme A, Laban S, Knecht R
EUR ARCH OTO-RHINO-L. 2012;269(11):2303-2308.

Neue Therapieaspekte bei Rezidiv und Fernmetastase des Kopf- und Hals-Karzinoms
Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T
HNO. 2012;60(11):957-61.

[New aspects in the therapy of recurrence and metastasis of head and neck cancer: highlights from the 2012 ASCO meeting].
Schöpper S, Laban S, Güldenzoph B, Münscher A, Knecht R, Kurzweg T
HNO. 2012;60(11):957-961.

HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.
Tribius S, Hoffmann A, Bastrop S, Görögh T, Haag J, Röcken C, Clauditz T, Grob T, Wilczak W, Tennstedt P, Borcherding A, Petersen C, Hoffmann M
ORAL ONCOL. 2012;48(11):1178-1184.

[Current status of therapeutic approaches with targeted therapies in malignant thyroid cancer. Highlights from the 2011 ASCO Congress].
Uecker F, Laban S, Knecht R
HNO. 2012;60(5):398, 400-403.

Non-beam hazards
Wöllmer W
2012. CMLSOs' Best Practices in Medical Laser Safety. LIA - Laser Institute of America: 57-70.

ADAM8 in squamous cell carcinoma of the head and neck: a retrospective study.
Zielinski V, Brunner M, Heiduschka G, Schneider S, Seemann R, Erovic B, Thurnher D
BMC CANCER. 2012;12:76.

[Infraorbital lesion after scuba diving with chronic sinusitis: diagnosis and treatment of reverse block].
Brocks C, Bergmann-Köster C, Wollenberg B, Graefe H
HNO. 2011;59(5):507-510.

Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas.
Clauditz T, Reiff M, Gravert L, Gnoss A, Tsourlakis M, Münscher A, Sauter G, Bokemeyer C, Knecht R, Wilczak W
PATHOLOGY. 2011;43(5):459-464.

Globusgefühl und Hustenreiz durch eine gestielte Raumforderung im Bereich des Waldeyer’schen Rachenrings
Laban S, Münscher A, Habermann C, Quaas A, Knecht R
GMS Curr Posters Otorhinolaryngol Head Neck Surg. 2011;7:42.

The endoscopic approach to the neck: a review of the literature, and overview of the various techniques.
Münscher A, Dalchow C, Kutta H, Knecht R
SURG ENDOSC. 2011;25(5):1358-1363.

The endoscopic approach to the neck
Münscher A, Dalchow C, Kutta H, Knecht R
Surgical endoscopy. 2011;25(5):1358-63.

Fluoreszeinaspiration während der Narkoseeinleitung
Olotu C, Münscher A, Schmidt G
ANAESTHESIST. 2011;60(8):740-2.

[Fluorescein aspiration during induction of anaesthesia : complication preceding surgical treatment of cerebrospinal fluid fistula].
Olotu C, Münscher A, Schmidt G
ANAESTHESIST. 2011;60(8):740-742.

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells.
Raab M, Kappel S, Krämer A, Sanhaji M, Matthess Y, Kurunci-Csacsko E, Calzada-Wack J, Rathkolb B, Rozman J, Adler T, Busch D, Esposito I, Fuchs H, Gailus-Durner V, Klingenspor M, Wolf E, Sänger N, Prinz F, Angelis M, Seibler J, Yuan J, Bergmann M, Knecht R, Kreft B, Strebhardt K
NAT COMMUN. 2011;2:395.

Complete activation of thyroid hormone receptor β by T3 is essential for normal cochlear function and morphology in mice.
Richter C, Münscher A, Machado D, Wondisford F, Ortiga-Carvalho T
CELL PHYSIOL BIOCHEM. 2011;28(5):997-1008.

Impact of HPV status on treatment of squamous cell cancer of the oropharynx: what we know and what we need to know.
Tribius S, Ihloff A, Rieckmann T, Petersen C, Hoffmann M
CANCER LETT. 2011;304(2):71-79.

Current concepts of organ preservation in head and neck cancer.
Wang C, Knecht R
EUR ARCH OTO-RHINO-L. 2011;268(4):481-487.

An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body.
Cao Y, Gordic M, Kobold S, Lajmi N, Meyer S, Bartels K, Hildebrandt Y, Luetkens T, Ihloff A, Kröger N, Bokemeyer C, Atanackovic D
J IMMUNOL METHODS. 2010;358(1-2):56-65.

p16(INK4a) overexpression predicts translational active human papillomavirus infection in tonsillar cancer.
Hoffmann M, Ihloff A, Görögh T, Weise J, Fazel A, Krams M, Rittgen W, Schwarz E, Kahn T
INT J CANCER. 2010;127(7):1595-1602.

Human papilloma virus in locally advanced stage III/IV squamous cell cancer of the oropharynx and impact on choice of therapy.
Ihloff A, Petersen C, Hoffmann M, Knecht R, Tribius S
ORAL ONCOL. 2010;46(10):705-711.

[HPV infection in head and neck squamous cell carcinoma (HNSCC). Highlights from ASCO 2010].
Ihloff A, Knecht R, Tribius S
HNO. 2010;58(12):1163-1167.

[Current therapy concepts in head and neck tumors. Post ASCO Congress].
Knecht R
HNO. 2010;58(12):1154-1155.

The value of digital volume tomography in assessing the position of cochlear implant arrays in temporal bone specimens.
Kurzweg T, Dalchow C, Bremke M, Majdani O, Kureck I, Knecht R, Werner J, Teymoortash A
EAR HEARING. 2010;31(3):413-419.

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment
Mautner V, Nguyen R, Knecht R, Bokemeyer C
ANN ONCOL. 2010;21(11):2294-5.

Radiographic regression of vestibular schwannomas induced by bevacizumab treatment: sustain under continuous drug application and rebound after drug discontinuation.
Mautner V, Nguyen R, Knecht R, Bokemeyer C
ANN ONCOL. 2010;21(11):2294-2295.

[The current value of induction chemotherapy. ASCO Congress 2010].
Mumme A, Reitmeier F, Knecht R
HNO. 2010;58(12):1156, 1158, 1160-1162.

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.
Psyrri A, Licitra L, Lacombe D, Schuuring E, Budach W, Ozsahin M, Knecht R, Vermorken J, Langendijk J
ANN ONCOL. 2010;21(10):1952-1960.

[Radiation therapy in head and neck cancer. Highlights from ASCO 2010].
Tribius S, Petersen C, Knecht R, Ihloff A
HNO. 2010;58(12):1168-1173.

Endotracheal tube fires still happen A short overview
Wöllmer W, Schade G, Kessler T
Med Laser Appl. 2010;25(2):118-125.

Notfälle, Problemsituationen und differentialdiagnostische Gesichtspunkte
Alberty J, Guntinas-Lichias O, Kochs E, Metternich F, Müller A, Müller R, Plontke S, Raeft A, Reiß G, Reiß M, Schönweiler B, Schönweiler R, Waldfahrer F, Weber R
2009. Facharztwissen HNO-Heilkunde: Differenzierte Diagnostik und Therapie. Springer Medizin Verlag: 1011-1054.

Chirurgische Therapie
Baghi M, Bloching M, Hosemann W, Iro H, Jungchülsing M, Knecht R, Kochs E, Lippert B, Mattheis S, Mir-Salim P, Müller A, Ranft A, Reiß G, Reiß M, Remmert S, Siegert R, Tasman A, Verse T, Waldfahrer F, Weber R, Zenk J
2009. Facharztwissen HNO-Heilkunde: Differenzierte Diagnostik und Therapie. Springer Medizin Verlag: 845-1000.

Lippen, Mundhöhle und Pharynx
Baier G, Baumann I, Bisdas S, Brockmeyer N, Claassen H, Dlugaiczyk J, Guntinas-Lichius O, Heckmann J, Herzog M, Hummel T, Lippert B, Maune S, Metternich F, Müller R, Paulsen F, Potthoff A, Reiß G, Reiß M, Schick B, Schönweiler B, Schönweiler R, Verse T, Vogl T, Waldfahrer F
2009. Facharztwissen HNO-heilkunde: Differenzierte Diagnostik und Therapie. Springer Medizin Verlag: 433-518.

Larynx
Barghi M, Bidas S, Claassen H, Issing P, Knecht R, Paulsen F, Müller A, Müller R, Reiß G, Reiß M, Remmert S, Schönweiler B, Schönweiler R, Vogel T
2009. Facharztwissen HNO-Heilkunde: Differenzierte Diagnostik und Therapie. Springer Medizin Verlag: 561-606.

Medikamentöse Therapie
Brockmeyer N, Ebner W, Frank U, Jäckel M, Kirch W, Laskawi R, Leithäuser D, Metternich F, Meyer E, Michel O, Plontke S, Potthoff A, Reiß G, Reiß M, Rudack C, Sauerbrei A
2009. Facharztwissen HNO-heilkunde: Differenzierte Diagnostik und Therapie. Springer Medizin Verlag: 743-788.

[Acromegaly-associated lesions of the nasal mucosa : Case report.]
Flitsch J, Lüdecke D, Saeger W, Veit J, Metternich F
HNO. 2009.

The German Mouse Clinic: a platform for systemic phenotype analysis of mouse models.
Fuchs H, Gailus-Durner V, Adler T, Pimentel J, Becker L, Bolle I, Brielmeier M, Calzada-Wack J, Dalke C, Ehrhardt N, Fasnacht N, Ferwagner B, Frischmann U, Hans W, Hölter S, Hölzlwimmer G, Horsch M, Javaheri A, Kallnik M, Kling E, Lengger C, Maier H, Mossbrugger I, Mörth C, Naton B, Nöth U, Pasche B, Prehn C, Przemeck G, Puk O, Racz I, Rathkolb B, Rozman J, Schäble K, Schreiner R, Schrewe A, Sina C, Steinkamp R, Thiele F, Willershäuser M, Zeh R, Adamski J, Busch D, Beckers J, Behrendt H, Daniel H, Esposito I, Favor J, Graw J, Heldmaier G, Höfler H, Ivandic B, Katus H, Klingenspor M, Klopstock T, Lengeling A, Mempel M, Müller W, Neschen S, Ollert M, Quintanilla-Martinez L, Rosenstiel P, Schmidt J, Schreiber S, Schughart K, Schulz H, Wolf E, Wurst W, Zimmer A, Hrabé de Angelis M
CURR PHARM BIOTECHNO. 2009;10(2):236-243.

Tympanic Membrane Boundary Deformations Derived from Static Displacements Observed with Computerized Tomography in Human and Gerbil.
Gea S, Decraemer W, Funnell R, Dirckx J, Maier H
JARO-J ASSOC RES OTO. 2009.

NY-CO-58/KIF2C is overexpressed in a variety of solid tumors and induces frequent T cell responses in patients with colorectal cancer.
Gnjatic S, Cao Y, Reichelt U, Yekebas E, Nölker C, Marx A, Erbersdobler A, Nishikawa H, Hildebrandt Y, Bartels K, Horn C, Stahl T, Gout I, Filonenko V, Ling K, Cerundolo V, Luetkens T, Ritter G, Friedrichs K, Leuwer R, Hegewisch-Becker S, Izbicki J, Bokemeyer C, Old L, Atanackovic D
INT J CANCER. 2009.

Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible?
Habermann C, Arndt C, Graessner J, Diestel L, Petersen K, Reitmeier F, Ussmueller J, Adam G, Jaehne M
AM J NEURORADIOL. 2009;30(3):591-596.

[Radiotherapy, chemotherapy and target therapy for treatment of head and neck cancer : new developments]
Knecht R
HNO. 2009;57(5):436-445.

Larynx preservation clinical trial design: key issues and recommendations--a consensus panel summary
Lefebvre J, Bardet E, Barry B, Bernier J, Bourhis J, Budach V, Calais G, Conley B, Forastiere A, Knecht R, Langendijk J, Leemans R, Licitra L, Posner M, de Raucourt D, Rolland F, Temam S, Vermorken J, Vokes E, Weber R, Wolf G, Ang K
HEAD NECK-J SCI SPEC. 2009;31(4):429-441.

Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.
Lorenz K, Maier H
EUR ARCH OTO-RHINO-L. 2009;266(12):1937-1944.

[Surgical treatment of enlarged trachoesophageal puncture with and without supraesophageal reflux : case report and review of literature]
Lorenz K, Maier H
HNO. 2009;57(12):1317-1324.

[Pulmonary rehabilitation after total laryngectomy using a heat and moisture exchanger (HME)]
Lorenz K, Maier H
LARYNGORHINOOTOLOGIE. 2009;88(8):513-522.

[Finger-free speech with the Provox FreeHands HME Automatic Tracheostoma Valve system. Clinical long-term experience]
Lorenz K, Huverstuhl K, Maier H
HNO. 2009;57(11):1090-1098.

[Coincidence of fistula enlargement and supra-oesophageal reflux in patients after laryngectomy and prosthetic voice restoration]
Lorenz K, Ehrhart T, Grieser L, Maier H
HNO. 2009;57(12):1253-1261.

[Penetrating gunshot wound in the neck. Case report and review of the literature]
Maier H, Tisch M, Steinhoff S, Lorenz K
HNO. 2009;57(8):839-844.

Temporal bone imaging: comparison of flat panel volume CT and multisection CT.
Majdani O, Thews K, Bartling S, Leinung M, Dalchow C, Labadie R, Lenarz T, Heidrich G
AM J NEURORADIOL. 2009;30(7):1419-1424.

Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer.
Möckelmann N, von Schönfels W, Buch S, von Kampen O, Sipos B, Egberts J, Rosenstiel P, Franke A, Brosch M, Hinz S, Röder C, Kalthoff H, Fölsch U, Krawczak M, Schreiber S, Bröring C, Tepel J, Schafmayer C, Hampe J
BMC GASTROENTEROL. 2009;9:79.

TROP2 expression as prognostic marker for gastric carcinoma.
Mühlmann G, Spizzo G, Gostner J, Zitt M, Maier H, Moser P, Gastl G, Müller H, Margreiter R, Ofner D, Fong D
J CLIN PATHOL. 2009;62(2):152-158.

Benign and malignant salivary gland diseases in children A retrospective study of 549 cases from the Salivary Gland Registry, Hamburg.
Münscher A, Diegel T, Jaehne M, Ussmüller J, Koops S, Sanchez-Hanke M
AURIS NASUS LARYNX. 2009;36(3):326-331.

Integration of human papilloma virus type 26 in laryngeal cancer of a child.
Münscher A, Feucht H, Kutta H, Tesche S, Wenzel S
AURIS NASUS LARYNX. 2009;36(2):232-234.

[Laryngeal squamous cell carcinoma in a 12-year-old boy]
Münscher A, Feucht H, Kutta H, Tesche S, Wenzel S
HNO. 2009;57(6):617-620.

Plattenepithelkarzinom des Larynx bei einem 12-jährigen Jungen
Münscher A, Feucht H, Kutta H, Tesche S, Wenzel S, Münscher A
HNO. 2009;57(6):617-20.

Direct quantification of polo-like kinase 1 activity in cells and tissues using a highly sensitive and specific ELISA assay.
Park J, Li L, Park J, Knecht R, Strebhardt K, Yuspa S, Lee K
P NATL ACAD SCI USA. 2009;106(6):1725-1730.

NKCC1-dependent GABAergic excitation drives synaptic network maturation during early hippocampal development.
Pfeffer C, Stein V, Keating D, Maier H, Rinke I, Rudhard Y, Hentschke M, Rune G, Jentsch T, Hübner C
J NEUROSCI. 2009;29(11):3419-3430.

Sjögren's syndrome of the parotid gland: value of diffusion-weighted echo-planar MRI for diagnosis at an early stage based on MR sialography grading in comparison with healthy volunteers.
Regier M, Ries T, Arndt C, Cramer M, Graessner J, Reitmeier F, Jaehne M, Adam G, Habermann C
ROFO-FORTSCHR RONTG. 2009;181(3):242-248.

Chromogranin peptides in amyotrophic lateral sclerosis.
Schrott-Fischer A, Bitsche M, Humpel C, Walcher C, Maier H, Jellinger K, Rabl W, Glueckert R, Marksteiner J
REGUL PEPTIDES. 2009;152(1-3):13-21.

[Semi-implantable hearing aids for sensorineural hearing loss and combined hearing loss: experiences at the German Armed Forces Hospital in Ulm]
Tisch M, Maier H
HNO. 2009;57(3):208-215.

Signet ring cell adenocarcinoma of the oropharynx: presentation of a rare case and review of the literature.
Veit J, Reichelt U, Tesche S
AURIS NASUS LARYNX. 2009.

Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell lines.
Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstöttner W, Ackermann H, May A, Hambek M, Knecht R
J CANCER RES CLIN. 2009;135(3):387-393.

Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients.
Baghi M, Wagenblast J, Hambek M, Moertel S, Gstoettner W, Strebhardt K, Knecht R
CLIN OTOLARYNGOL. 2008;33(3):245-251.

Aerosolized iloprost in the treatment of pulmonary hypertension in extremely preterm infants: a pilot study.
Eifinger F, Sreeram N, Mehler K, Huenseler C, Kribs A, Roth B
KLIN PADIATR. 2008;220(2):66-69.

Severe Ecstasy poisoning in an 8-month-old infant.
Eifinger F, Roth B, Kröner L, Rothschild M
EUR J PEDIATR. 2008;167(9):1067-1070.

Prospective evaluation of the pharmacodynamics of piritramide in neonates and infants.
Huenseler C, Borucki D, Mueller C, Hering F, Kremer W, Theisohn M, Roth B
EUR J PEDIATR. 2008;167(8):867-872.

Schmerzlose zervikale Raumforderung eines Jugendlichen
Kutta H, Schäfer H, Münscher A, Wenzel S
HNO. 2008;56(8):813-6.

Distribution of mucins and antimicrobial substances lysozyme and lactoferrin in the laryngeal subglottic region.
Kutta H, Willer A, Steven P, Bräuer L, Tsokos M, Paulsen F
J ANAT. 2008;213(4):473-481.

[Painless cervical mass in an adolescent]
Kutta H, Schäfer H, Münscher A, Wenzel S
HNO. 2008;56(8):813-816.

Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV.
Rickheit G, Maier H, Strenzke N, Andreescu C, Zeeuw D, Münscher A, Muenscher A, Zdebik A, Jentsch T
EMBO J. 2008;27(21):2907-2917.

Endocochlear potential depends on Cl- channels
Rickheit G, Maier H, Strenzke N, Andreescu C, De Zeeuw C, Muenscher A, Zdebik A, Jentsch T
EMBO J. 2008;27(21):2907-17.

Value of apparent diffusion coefficient calculation before and after gustatory stimulation in the diagnosis of acute or chronic parotitis.
Ries T, Schröter C, Regier M, Graessner J, Cramer M, Reitmeier F, Jaehne M, Adam G, Habermann C
EUR RADIOL. 2008;18(10):2251-2257.

Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy?
Schwartz-Albiez R, Laban S, Eichmüller S, Kirschfink M
AUTOIMMUN REV. 2008;7(6):491-495.

[Update on physiology and pathophysiology of the inner ear: pathomechanisms of sensorineural hearing loss]
Strenzke N, Pauli-Magnus D, Meyer A, Brandt A, Maier H, Moser T
HNO. 2008;56(1):27-36.

The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. Results of a double-blind, randomised, controlled trial.
Tesche S, Metternich F, Sonnemann U, Engelke J, Dethlefsen U
EUR ARCH OTO-RHINO-L. 2008;265(11):1355-1359.

Deafness in mice lacking the T-box transcription factor Tbx18 in otic fibrocytes.
Trowe M, Maier H, Schweizer M, Kispert A
DEVELOPMENT. 2008;135(9):1725-1734.

[Management of traumatic tracheal injuries: presentation of a rare case and review of the literature]
Veit J, Metternich F
LARYNGORHINOOTOLOGIE. 2008;87(4):270-273.

[Guideline: treatment of adult obstructive sleep apnea]
Verse T, de La Chaux R, Dreher A, Fischer Y, Grundmann T, Hecksteden K, Hörmann K, Hohenhorst W, Ilgen F, Kühnel T, Mahl N, Maurer J, Pirsig W, Roth B, Siegert R, Stuck B
LARYNGORHINOOTOLOGIE. 2008;87(3):192-204.

Effect of bortezomib on EGFR expression in head and neck squamous cell carcinoma cell lines.
Wagenblast J, Hambek M, Baghi M, Knecht R
ANTICANCER RES. 2008;28(2):687-692.

Effect of bortezomib and cetuximab in EGF-stimulated HNSCC.
Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstöttner W, Ackermann H, May A, Knecht R, Hambek M
ANTICANCER RES. 2008;28(4):2239-2243.

Antiproliferative activity of bortezomib alone and in combination with cisplatin or docetaxel in head and neck squamous cell carcinoma cell lines.
Wagenblast J, Hambek M, Baghi M, Gstöttner W, Strebhardt K, Ackermann H, Knecht R
J CANCER RES CLIN. 2008;134(3):323-330.

Effects of combination treatment of bortezomib and dexamethasone in SCCHN cell lines depend on tumor cell specificity.
Wagenblast J, Baghi M, Arnoldner C, Bisdas S, Gstöttner W, May A, Knecht R, Hambek M
ONCOL REP. 2008;20(5):1207-1211.

[Ultrafast MR sialography: comparison of two coil systems including an alternative surface coil]
Weber C, Cramer M, Dichtl D, Weiss F, Petersen K, Reitmeier F, Jaehne M, Adam G, Habermann C
ROFO-FORTSCHR RONTG. 2008;180(11):977-982.

Letzte Aktualisierung aus dem FIS: 29.05.2017 - 00:15 Uhr